Draft patent amendment rules undermine pre-grant opposition
The draft patent amendment rules made public on August 23 this year could hugely benefit big pharma but turn out to be disastrous for patients in India and in countries in the global South, which rely on generic drugs manufactured in India, in accessing affordable drugs and vaccines. The draft rules released by the Department for…
Read More “Draft patent amendment rules undermine pre-grant opposition” »